Niagen Bioscience Inc

General ticker "NAGE" information:

  • Sector: Health Care
  • Industry: Biotechnology
  • Capitalization: $626.1M (TTM average)

Niagen Bioscience Inc does not follow the US Stock Market performance with the rate: -27.7%.

Estimated limits based on current volatility of 2.2%: low 3.41$, high 3.56$

Factors to consider:

  • Current price 21.8% below estimated low
  • Earnings for 3 months up through Q1 exceed our estimates

Stock Forecast*

* forecast is subjective and experimental, should not be used for any investment decisions

Long term estimates were made for the period from 2025-12-31 to 2027-12-31

  • 2025-12-31 to 2026-12-31 estimated range: [4.31$, 8.35$]
  • 2026-12-31 to 2027-12-31 estimated range: [4.20$, 8.11$]

Financial Metrics affecting the NAGE estimates:

  • Positive: with PPE of 40.8 at the end of fiscal year the price was low
  • Positive: 7.54 < Operating profit margin, % of 11.05
  • Positive: Return on assets ratio (scaled to [-100,100]) of 14.04 > 6.06
  • Negative: Shareholder equity ratio, % of 71.93 > 64.29
  • Positive: Investing cash flow per share per price, % of -0.06 > -0.60
  • Negative: negative Industry operating cash flow (median)
  • Negative: negative Industry operating income (median)
  • Positive: Industry inventory ratio change (median), % of 0 <= 0

Similar symbols

Short-term NAGE quotes

Long-term NAGE plot with estimates

Financial data

YTD 2023-12-31 2024-12-31 2025-12-31
Operating Revenue $83.57MM $99.60MM $129.42MM
Operating Expenses $89.17MM $91.87MM $115.13MM
Operating Income $-5.60MM $7.73MM $14.30MM
Non-Operating Income $0.66MM $1.13MM $3.90MM
R&D Expense $4.96MM $6.02MM $6.33MM
Income(Loss) $-4.94MM $8.86MM $18.19MM
Taxes $0.00MM $0.30MM $0.81MM
Net Income(Loss)* $-4.94MM $8.55MM $17.38MM
Stockholders Equity $28.46MM $46.09MM $76.53MM
Inventory $14.53MM $9.19MM $20.42MM
Assets $54.96MM $68.28MM $106.41MM
Operating Cash Flow $7.12MM $12.11MM $13.44MM
Capital expenditure $0.15MM $0.16MM $0.29MM
Investing Cash Flow $-0.14MM $-0.14MM $-0.29MM
Financing Cash Flow $-0.09MM $5.37MM $6.98MM
Earnings Per Share** $-0.07 $0.10 $0.22

* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.